Carolinas Wealth Consulting’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,210
Closed -$16.6K 1147
2023
Q4
$16.6K Hold
1,210
﹤0.01% 477
2023
Q3
$17.8K Buy
1,210
+22
+2% +$275 ﹤0.01% 448
2023
Q2
$15.5K Hold
1,188
﹤0.01% 522
2023
Q1
$14.6K Buy
1,188
+24
+2% +$257 ﹤0.01% 543
2022
Q4
$10.2K Buy
1,164
+11
+1% +$116 ﹤0.01% 622
2022
Q3
$12K Buy
1,153
+8
+0.7% +$106 ﹤0.01% 543
2022
Q2
$15K Hold
1,145
﹤0.01% 512
2022
Q1
$17K Buy
1,145
+6
+0.5% +$101 ﹤0.01% 520
2021
Q4
$20K Buy
+1,139
New +$23.5K ﹤0.01% 499

Other funds holding SWBI

Carolinas Wealth Consulting's SWBI Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Smith & Wesson (SWBI) in Q1 2024, closing a stake of 1,210 shares — an estimated $16.6K sold.

Carolinas Wealth Consulting first reported a position in SWBI in Q4 2021 and held it in 9 quarters. The position peaked at $20K in Q4 2021. 185 funds tracked by Wall St. Rank hold SWBI as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Smith & Wesson position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 1,210 Smith & Wesson shares in Q1 2024, an estimated $16.6K.
  • Carolinas Wealth Consulting first reported a position in Smith & Wesson in Q4 2021 and held it in 9 quarters.
  • Carolinas Wealth Consulting's Smith & Wesson position peaked at $20K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.